Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Gilead Sciences (GILD) Q1 2020 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Thursday said its first-quarter earnings increased, aided by higher revenues. The results also exceeded the market’s prediction. The company did not provide guidance for fiscal 2020, due to the coronavirus-driven uncertainty.
First-quarter adjusted earnings increased to $1.68 per share from $1.67 per share a year earlier. Analysts were looking for a smaller bottom-line number.
Net income, on an unadjusted basis, came in at $1.55 billion or $1.22 per share, compared to $1.98 billion or $1.54 per share in the prior-year period. The improvement primarily reflects favorable tax effects and gains from equity securities.
Revenues moved up 5% year-over-year to $5.55 billion and exceeded the market’s prediction. The company’s stock closed Thursday’s regular trading higher, hut slipped into the negative territory during the after-hours session.
Most Popular
Kroger’s Q3 report likely to reflect consumer caution amid macro headwinds
The Kroger Co. (NYSE: KR) is preparing to report third-quarter results this week while navigating a challenging market environment. In the first half, the grocery chain's performance was not very
Estee Lauder (EL): A look at the challenges weighing down this beauty giant
Shares of The Estée Lauder Companies Inc. (NYSE: EL) rose over 2% on Monday. The stock has dropped 19% over the past three months. The beauty company had a disappointing
Hormel Foods (HRL) to report Q4 2024 earnings results, a look at what to expect
Shares of Hormel Foods Corporation (NYSE: HRL) rose over 1% on Friday. The stock has gained over 5% in the past one month. The branded food company is slated to
